Skip to main content
. 2022 Sep 23;13:987882. doi: 10.3389/fphar.2022.987882

TABLE 2.

Plasma protein binding of AGS IV and LS-102 plus site markers in HSA (‾ x ± s, n = 3).

Analyte Without site markers With warfarin (mg/ml) With ibuprofen (mg/ml)
0.06 0.3 1.2 0.06 0.3 1.2
AGS IV 96.67±1.14 94.90±1.95 91.10±1.06* 92.19±2.38* 92.82±1.44 93.87±2.26 97.19±1.37
LS-102 66.90±0.93 53.29±2.14** 58.93±0.98** 54.70±1.25** 63.22±0.72 75.16±1.99* 72.03±1.83*

* p < 0.05.

** p < 0.01, vs. analytes without site markers.